Abstract and Instructional Course Submissions

When available, we will provide a link that will take you directly to the Annual Meeting/Specialty Day Abstract Center and Instructional Course Submission site.

AOSSM Members: You can log in to the abstract center using your AOSSM username and password.

Non-members: If you previously submitted an abstract, you may already have a username and password. If so, try the “Forgot my password” link and type your email address in the box. If you don’t get a username/password from that, create an account.

If you are not a member and have not used the abstract center before, you can simply register by clicking on the red “Create an Account” button.

There is no limit to the number of abstracts you may submit. There is a $50 fee for each abstract submitted. This fee helps to defray the cost of maintaining the abstract center.

All abstracts submitted must be original science, not previously presented as peer-reviewed original science at any other regional, national, or international scientific conference.

Abstracts previously published (even in an AOSSM Journal) are not eligible for presentation at an AOSSM meeting. If an abstract is accepted for an AOSSM meeting that includes abstract or at a non-AOSSM meeting, it cannot be submitted. If acceptance to another event occurs after the submission deadlines, the submitter is required to withdraw their abstract. Please contact [email protected] with any questions.

Abstracts presented as part of the AOSSM Annual Meeting/Specialty Day comprise a five-minute podium or poster presentation.

Instructional courses are 90 minutes in length and are presented in a traditional or round-table discussion format at the AOSSM Annual Meeting.

There is a 5,000-character maximum.

Abstract format is:

• Title
• Introduction
• Objective
• Methods
• Results
• Conclusion

Please note: Abstracts selected for the Annual Meeting or Specialty Day cannot contain advertising, trade names, or a product-group message. Please include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used, not just trade names from a single company, in order to present all available treatment options. If trade names or company names are included in your abstract, we reserve the right to remove them to ensure all scientific content is free from commercial bias.

In accordance with ACCME standards, please note that the presenter of any accepted abstract cannot be employed by an ineligible company* (formerly referred to as a commercial interest.)

Up to four images may be attached to your submission.

Edits can be made until the Abstract Center submission deadline. Edits may include changing the title, adding, or deleting authors, or changing the abstract body. Once the review process begins, no changes to the submissions are allowed. Typographical or spelling errors, improperly formatted titles, etc., will not be edited by anyone at AOSSM. It is the responsibility of the submitter to review and verify all work submitted. After making changes to an abstract, remember to resubmit the abstract even if previously submitted.

All titles should be in “Title-case Format” with the first letter of each major word capitalized. Smaller conjunction or article words, such as “in, of, on, a, for” should be in lower case.

Example: The Effects of Glenohumeral Osteoarthritis on Early Clinical Outcomes Following Arthroscopic Rotator Cuff Repair

All abstracts are blindly reviewed by a committee of qualified orthopaedic sports medicine surgeons.

Notifications of the Annual Meeting abstract selection and Instructional Course Committee's decision will be sent early January via email to the presenting author of all abstracts as well as the submitter for Instructional Courses, regardless of the outcome.

Notification of Specialty Day abstract selection will be sent out in late July or early August.

Accredited as a CME provider by the Accreditation Council for Continuing Medical Education® (ACCME), the American Orthopaedic Society for Sports Medicine (AOSSM) has responsibility for the educational process. The AOSSM expects all its CME activities to be balanced, independent, objective, scientifically rigorous and in the best interest of patient care. The AOSSM mandates that promotion and education be separate and that the planning and development of its educational activities are not influenced by any commercial interests. The AOSSM attests that the person(s) responsible for development of this educational activity did so independently and were not influenced by commercial supporters.

The AOSSM requires that all faculty, planners, AOSSM leadership, and relevant members of the AOSSM professional team comply with the ACCME Standards for Commercial Support. To be compliant, each must disclose all financial relationships within the last twelve months with any commercial interest. An ACCME defined commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Consideration for participation as faculty and / or planning may be withdrawn if disclosure is not received in a timely manner. The AOSSM oversees the process and will give you ample opportunity to provide a disclosure prior to seeking a replacement. The AOSSM understands that financial commercial relationships do not automatically preclude the ability to provide a balanced, objective, and scientifically rigorous perspective and / or presentation(s).

The AOSSM relies on an internal review process to identify and resolve faculty and planner conflicts of interest (COI). If a disclosure reflects any such COI, the AOSSM will use the internal review process to resolve it and will communicate the resolution to the faculty or planner. The person must also assure the AOSSM that the written and verbal content of any presentation(s), educational product, faculty role, planning, or other educational involvement will be balanced, fair, scientifically rigorous, and in the best interest of patient care. Furthermore, the AOSSM learner evaluations assess the presence of commercial bias in all its educational activities, and those evaluations are monitored by the responsible oversight committee.

Expectations for faculty presentations are that they will be of the highest quality. The AOSSM is responsible for validating the clinical content of CME activities that are provided. All faculty and planners must agree to the following:

• All recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
• All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
• Content must be free from any commercial bias.
  • Strive to use generic names to the extent possible.
  • If trade names are used, reference several trade names, if available.
• Explicitly and clearly emphasize any investigational use of a commercial product or procedure. Explicitly and clearly emphasize any “off label” uses of a substance or product (not approved in the US for the use under discussion).
• Ensure that all presentations are HIPAA compliant.